Walleye Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1M | Buy |
183,818
+66,255
| +56% | +$12.3M | 0.13% | 59 |
|
|
2025
Q1 | $24.6M | Buy |
117,563
+116,476
| +10,715% | +$24.4M | 0.11% | 79 |
|
|
2024
Q4 | $193K | Sell |
1,087
-1,857
| -63% | -$330K | ﹤0.01% | 1518 |
|
|
2024
Q3 | $581K | Sell |
2,944
-99
| -3% | -$19.6K | ﹤0.01% | 1270 |
|
|
2024
Q2 | $522K | Sell |
3,043
-19,160
| -86% | -$3.29M | ﹤0.01% | 1434 |
|
|
2024
Q1 | $4.04M | Buy |
+22,203
| New | +$4.04M | 0.01% | 513 |
|
|
2023
Q4 | – | Sell |
-15,889
| Closed | -$2.37M | – | 2114 |
|
|
2023
Q3 | $2.37M | Sell |
15,889
-4,704
| -23% | -$701K | 0.01% | 599 |
|
|
2023
Q2 | $2.77M | Buy |
+20,593
| New | +$2.77M | 0.01% | 422 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2057 |
|
|
2022
Q4 | – | Sell |
-36,910
| Closed | -$4.95M | – | 2087 |
|
|
2022
Q3 | $4.95M | Sell |
36,910
-12,005
| -25% | -$1.61M | 0.09% | 220 |
|
|
2022
Q2 | $7.49M | Buy |
+48,915
| New | +$7.49M | 0.21% | 97 |
|
|
2022
Q1 | – | Sell |
-6,081
| Closed | -$823K | – | 2178 |
|
|
2021
Q4 | $823K | Sell |
6,081
-72,913
| -92% | -$9.87M | 0.03% | 683 |
|
|
2021
Q3 | $8.52K | Buy |
+78,994
| New | +$8.52K | 0.24% | 33 |
|
|
2020
Q2 | – | Sell |
-1,778
| Closed | -$135K | – | 589 |
|
|
2020
Q1 | $135K | Buy |
1,778
+708
| +66% | +$53.8K | 0.03% | 335 |
|
|
2019
Q4 | $95K | Buy |
1,070
+480
| +81% | +$42.6K | 0.01% | 474 |
|
|
2019
Q3 | $45K | Buy |
590
+310
| +111% | +$23.6K | ﹤0.01% | 359 |
|
|
2019
Q2 | $20K | Hold |
280
| – | – | ﹤0.01% | 396 |
|
|
2019
Q1 | $23K | Buy |
+280
| New | +$23K | ﹤0.01% | 287 |
|